Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aliza Brown

Concepts (248)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
13
2020
527
2.420
Why?
Thrombolytic Therapy
8
2020
113
1.100
Why?
Tissue Plasminogen Activator
9
2020
108
1.070
Why?
Brain Ischemia
5
2020
168
0.960
Why?
Endarterectomy, Carotid
9
2011
60
0.830
Why?
Thrombectomy
2
2020
74
0.800
Why?
Health Services Misuse
1
2020
13
0.660
Why?
Fibrinolytic Agents
7
2020
131
0.650
Why?
Tunica Intima
8
2011
55
0.650
Why?
Time-to-Treatment
1
2020
77
0.630
Why?
Patient Transfer
1
2020
99
0.630
Why?
Homocysteine
7
2011
127
0.600
Why?
Disease Models, Animal
12
2015
1483
0.550
Why?
Pneumonia, Viral
1
2020
175
0.520
Why?
Microbubbles
3
2011
27
0.520
Why?
Emergency Service, Hospital
2
2020
521
0.520
Why?
Coronavirus Infections
1
2020
188
0.520
Why?
Emergency Medical Technicians
1
2016
8
0.500
Why?
Carotid Arteries
6
2010
77
0.500
Why?
Fluorocarbons
4
2019
59
0.460
Why?
Emergency Medical Services
1
2016
123
0.460
Why?
Ultrasonic Therapy
3
2011
30
0.450
Why?
Acetaminophen
3
2011
272
0.440
Why?
Acetylcysteine
2
2011
101
0.430
Why?
Quality Improvement
1
2016
226
0.430
Why?
Cerebral Hemorrhage
3
2015
102
0.370
Why?
Rural Population
1
2016
587
0.360
Why?
Liver Failure, Acute
1
2011
56
0.350
Why?
Intracranial Embolism
2
2012
29
0.350
Why?
Rabbits
10
2016
370
0.340
Why?
Carotid Stenosis
4
2011
61
0.290
Why?
Animals
26
2016
13485
0.270
Why?
Time Factors
11
2020
2987
0.250
Why?
Neuroprotective Agents
2
2019
103
0.250
Why?
Insulin Resistance
2
2010
281
0.250
Why?
Magnetic Resonance Imaging
2
2014
1507
0.240
Why?
Male
22
2020
26874
0.200
Why?
Platelet Aggregation Inhibitors
4
2006
211
0.190
Why?
Brain
1
2010
1337
0.180
Why?
Rats
12
2011
3228
0.180
Why?
United States
4
2020
5215
0.170
Why?
Rats, Sprague-Dawley
9
2011
1558
0.170
Why?
Hyperplasia
8
2011
96
0.160
Why?
Triage
1
2020
66
0.160
Why?
Conflict of Interest
1
2020
24
0.160
Why?
Disease Outbreaks
1
2020
121
0.150
Why?
Fabry Disease
1
2019
9
0.150
Why?
Angiography, Digital Subtraction
2
2011
27
0.150
Why?
Enzyme Replacement Therapy
1
2019
17
0.150
Why?
Carotid Artery, Common
2
2011
44
0.150
Why?
Ischemic Attack, Transient
1
2019
60
0.150
Why?
Cardiology
1
2020
105
0.140
Why?
Cerebral Angiography
3
2012
90
0.140
Why?
Humans
13
2020
52441
0.140
Why?
Cohort Studies
1
2020
1576
0.120
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
3
2004
56
0.120
Why?
Middle Aged
7
2020
13133
0.120
Why?
Infarction, Anterior Cerebral Artery
1
2015
2
0.120
Why?
Pandemics
1
2020
580
0.120
Why?
Aged
6
2020
10242
0.120
Why?
Follow-Up Studies
1
2020
2294
0.120
Why?
Female
12
2020
28277
0.110
Why?
Retrospective Studies
4
2020
6694
0.110
Why?
Infarction, Middle Cerebral Artery
1
2015
42
0.110
Why?
Ticlopidine
2
2006
71
0.110
Why?
Antidotes
2
2011
27
0.110
Why?
Prospective Studies
1
2020
2433
0.110
Why?
Receptors, N-Methyl-D-Aspartate
2
2005
126
0.110
Why?
Salivary Proteins and Peptides
2
2004
8
0.110
Why?
L-Lactate Dehydrogenase
1
2014
64
0.110
Why?
Posterior Leukoencephalopathy Syndrome
1
2014
42
0.100
Why?
Fractures, Spontaneous
1
2013
15
0.100
Why?
Fractures, Compression
1
2013
17
0.100
Why?
Models, Animal
4
2011
230
0.100
Why?
Spine
1
2013
86
0.100
Why?
Telemedicine
1
2019
490
0.100
Why?
Treatment Outcome
5
2019
5508
0.100
Why?
Analysis of Variance
2
2011
558
0.090
Why?
Expectorants
1
2011
14
0.090
Why?
Echinomycin
1
2011
6
0.090
Why?
Carotid Artery Injuries
1
2011
11
0.090
Why?
Circle of Willis
1
2011
2
0.090
Why?
Statistics as Topic
1
2011
89
0.090
Why?
Sensitivity and Specificity
2
2011
871
0.090
Why?
Cerebral Infarction
1
2011
35
0.090
Why?
Ultrasonography, Doppler, Transcranial
1
2011
20
0.090
Why?
Intracranial Hemorrhages
1
2011
43
0.090
Why?
Sinus Thrombosis, Intracranial
1
2010
17
0.080
Why?
Acarbose
1
2010
2
0.080
Why?
Receptors, Adrenergic, beta-2
1
2000
16
0.080
Why?
Indocyanine Green
1
2010
29
0.080
Why?
Analgesics, Non-Narcotic
1
2011
118
0.080
Why?
Hepatocytes
1
2011
184
0.080
Why?
Estradiol
1
2011
226
0.080
Why?
Subarachnoid Hemorrhage
1
2010
62
0.080
Why?
Trachea
1
2000
55
0.080
Why?
Ultrasonography, Interventional
1
2010
137
0.080
Why?
Adult
4
2020
14205
0.080
Why?
Radiography
1
2010
469
0.070
Why?
Arkansas
3
2019
2013
0.070
Why?
Glucocorticoids
1
2000
234
0.070
Why?
Dietary Sucrose
2
2010
14
0.070
Why?
Hypoglycemic Agents
1
2010
223
0.070
Why?
Dexamethasone
1
2000
434
0.070
Why?
Reproducibility of Results
1
2011
1223
0.070
Why?
Cystathionine beta-Synthase
2
2004
20
0.070
Why?
Ketorolac Tromethamine
1
2007
2
0.070
Why?
Myocytes, Smooth Muscle
2
2005
95
0.070
Why?
Cyclooxygenase Inhibitors
1
2007
39
0.070
Why?
Recovery of Function
2
2019
201
0.070
Why?
Mice
3
2011
5899
0.070
Why?
Cerebral Veins
1
2007
17
0.060
Why?
Drug Administration Schedule
2
2019
370
0.060
Why?
Cerebral Arteries
1
2007
30
0.060
Why?
Random Allocation
3
2015
286
0.060
Why?
Pravastatin
1
2006
18
0.060
Why?
Insulin
2
2010
485
0.060
Why?
Antineoplastic Agents
1
2014
1216
0.060
Why?
Antioxidants
1
2007
255
0.060
Why?
Blood Platelets
2
2006
239
0.060
Why?
Liver
1
2010
1150
0.060
Why?
Constriction
1
2004
8
0.060
Why?
Smoke
1
2004
18
0.060
Why?
Platelet Aggregation
1
2005
76
0.060
Why?
Muscle, Smooth, Vascular
1
2005
135
0.050
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
148
0.050
Why?
Cell Division
1
2005
288
0.050
Why?
Databases, Factual
2
2020
721
0.050
Why?
Neoplasms
1
2014
1314
0.050
Why?
Emulsions
2
2015
25
0.050
Why?
Cystathionine gamma-Lyase
1
2003
6
0.050
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.050
Why?
Postoperative Period
1
2004
169
0.050
Why?
Endothelium, Vascular
1
2005
263
0.050
Why?
Saphenous Vein
1
2004
63
0.050
Why?
Arterial Occlusive Diseases
1
2004
80
0.050
Why?
Lower Extremity
1
2004
97
0.050
Why?
Oxidative Stress
1
2007
805
0.050
Why?
Dietary Carbohydrates
1
2003
91
0.050
Why?
Diet
2
2005
591
0.050
Why?
Dietary Fats
1
2003
134
0.050
Why?
Preoperative Care
1
2004
173
0.050
Why?
Folic Acid
1
2003
137
0.050
Why?
Collagen
1
2003
215
0.050
Why?
Renal Dialysis
1
2003
189
0.050
Why?
Dose-Response Relationship, Drug
3
2011
1365
0.040
Why?
Health Care Sector
1
2020
15
0.040
Why?
Tomography, X-Ray Computed
2
2018
1140
0.040
Why?
Drug Industry
1
2020
39
0.040
Why?
Maximum Tolerated Dose
1
2019
39
0.040
Why?
alpha-Galactosidase
1
2019
9
0.040
Why?
Administration, Intravenous
1
2019
73
0.040
Why?
Disability Evaluation
1
2019
92
0.040
Why?
Multiple Myeloma
1
2013
3013
0.040
Why?
Cell Count
2
2005
143
0.030
Why?
Double-Blind Method
1
2019
726
0.030
Why?
Referral and Consultation
1
2019
288
0.030
Why?
Blotting, Western
2
2005
587
0.030
Why?
Glutamates
1
2016
22
0.030
Why?
Gene Expression Regulation
2
2011
1004
0.030
Why?
Angiography
1
2016
111
0.030
Why?
Single-Blind Method
1
2015
118
0.030
Why?
Drug Evaluation, Preclinical
1
2015
141
0.030
Why?
Infusions, Intravenous
1
2015
212
0.030
Why?
Reperfusion Injury
1
2015
73
0.030
Why?
Blood Chemical Analysis
1
2014
26
0.030
Why?
Immunohistochemistry
2
2005
977
0.020
Why?
Infusion Pumps, Implantable
1
2011
14
0.020
Why?
Angioplasty
1
2011
21
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2011
68
0.020
Why?
Jugular Veins
1
2011
28
0.020
Why?
Hyperhomocysteinemia
1
2011
29
0.020
Why?
Liver Regeneration
1
2011
46
0.020
Why?
Estrogen Replacement Therapy
1
2011
41
0.020
Why?
Ovariectomy
1
2011
115
0.020
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2011
60
0.020
Why?
Statistics, Nonparametric
1
2011
199
0.020
Why?
Chi-Square Distribution
1
2011
292
0.020
Why?
Vascular Endothelial Growth Factor A
1
2011
186
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2000
4
0.020
Why?
Injections, Intravenous
1
2010
130
0.020
Why?
Ultrasonography, Doppler, Pulsed
1
2010
2
0.020
Why?
Coloring Agents
1
2010
68
0.020
Why?
Phlebography
1
2010
54
0.020
Why?
Isoproterenol
1
2000
56
0.020
Why?
Luciferases
1
2000
50
0.020
Why?
Mice, Inbred Strains
1
2010
165
0.020
Why?
Adrenergic beta-Agonists
1
2000
39
0.020
Why?
Epithelium
1
2000
65
0.020
Why?
Alanine Transaminase
1
2010
119
0.020
Why?
Cyclic AMP
1
2000
90
0.020
Why?
Regional Blood Flow
1
2010
109
0.020
Why?
Blood Flow Velocity
1
2010
97
0.020
Why?
Propranolol
1
2000
76
0.020
Why?
Norepinephrine
1
2000
106
0.020
Why?
Epinephrine
1
2000
92
0.020
Why?
Transfection
1
2000
365
0.020
Why?
Cell Membrane
1
2000
238
0.020
Why?
Ultrasonography
1
2011
416
0.020
Why?
Transcription, Genetic
1
2000
375
0.020
Why?
DNA
1
2011
544
0.020
Why?
Cell Line
1
2000
1020
0.020
Why?
Malondialdehyde
1
2007
54
0.020
Why?
Blood Glucose
1
2010
483
0.020
Why?
Platelet Activation
1
2007
46
0.020
Why?
Triiodobenzoic Acids
1
2007
9
0.020
Why?
Glutathione
1
2007
301
0.020
Why?
Contrast Media
1
2007
173
0.010
Why?
Drug Combinations
1
2006
136
0.010
Why?
Aged, 80 and over
1
2013
3449
0.010
Why?
Dizocilpine Maleate
1
2005
15
0.010
Why?
Interleukin-1
1
2005
102
0.010
Why?
Cholesterol
1
2006
159
0.010
Why?
Matrix Metalloproteinase 9
1
2005
88
0.010
Why?
Excitatory Amino Acid Antagonists
1
2005
49
0.010
Why?
DNA, Complementary
1
2005
129
0.010
Why?
Homocystine
1
2004
8
0.010
Why?
Platelet Function Tests
1
2004
21
0.010
Why?
C-Reactive Protein
1
2006
151
0.010
Why?
Cell Culture Techniques
1
2005
97
0.010
Why?
Aorta, Thoracic
1
2005
98
0.010
Why?
Cotinine
1
2004
20
0.010
Why?
Probability
1
2004
171
0.010
Why?
Reference Values
1
2004
316
0.010
Why?
Cell Movement
1
2005
271
0.010
Why?
Biopsy, Needle
1
2004
181
0.010
Why?
RNA
1
2005
174
0.010
Why?
Ultrasonography, Doppler, Duplex
1
2004
21
0.010
Why?
Severity of Illness Index
1
2007
1045
0.010
Why?
Arginine
1
2005
183
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
580
0.010
Why?
Nitric Oxide
1
2005
238
0.010
Why?
Platelet Adhesiveness
1
2003
14
0.010
Why?
Signal Transduction
1
2000
1724
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Polytetrafluoroethylene
1
2003
33
0.010
Why?
Young Adult
1
2013
4346
0.010
Why?
Anastomosis, Surgical
1
2003
69
0.010
Why?
Vascular Patency
1
2003
82
0.010
Why?
Dogs
1
2003
183
0.010
Why?
Gene Expression
1
2005
618
0.010
Why?
Graft Occlusion, Vascular
1
2003
78
0.010
Why?
Extracellular Matrix
1
2003
116
0.010
Why?
RNA, Messenger
1
2005
1134
0.010
Why?
Adolescent
1
2013
6713
0.010
Why?
Cells, Cultured
1
2005
1583
0.010
Why?
Cell Proliferation
1
2005
1013
0.010
Why?
Models, Biological
1
2003
735
0.010
Why?
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description